Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis
Recommended Citation
Bunick CG, Bhatia N, Del Rosso J, Draelos ZD, Eichenfield LF, Kircik LH, Lebwohl MG, Gooderham M, Green LJ, Hebert AA, Vender RB, Zirwas M, Simpson EL, Stein Gold LF, Seal M, Snyder S, Osborne DW, Burnett P, Higham RC, Chu DH, Berk DR. Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis. Br J Dermatol 2024; 190:II9-II10.
Document Type
Conference Proceeding
Publication Date
8-2-2024
Publication Title
Br J Dermatol
Volume
190
First Page
II9
Last Page
II10
